Related Experiment Video
Updated: Feb 28, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Torsade de Pointes Induced by Hypokalemia from Imipenem and Piperacillin
Varun Kumar1, Sandeep Khosla1, Monica Stancu1
1Mount Sinai Hospital, Department of Cardiology, Suite L629, 1500 S. California Ave, Chicago, IL 60608, USA.
Abstract:
Imipenem-cilastatin and piperacillin-tazobactam are two antibiotics with broad antimicrobial coverage. Besides the many well established adverse effects of these drugs, there have been few case reports of hypokalemia. Here we present an interesting case of resistant hypokalemia caused by these drugs leading to Torsades de Pointes which has never been reported in the past. Hypokalemia resolved with discontinuation of piperacillin.
Insights
Broad-spectrum antibiotics imipenem-cilastatin and piperacillin-tazobactam can cause hypokalemia. This case highlights resistant hypokalemia and Torsades de Pointes from these drugs, resolving after piperacillin withdrawal.
Area of Science:
- Pharmacology
- Internal Medicine
- Cardiology
Background:
- Imipenem-cilastatin and piperacillin-tazobactam are broad-spectrum antibiotics.
- Adverse effects are known, but hypokalemia is rarely reported.
- Electrolyte disturbances can lead to cardiac arrhythmias.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Potassium-Sparing Diuretics
Desensitization and Tachyphylaxis
Heart Failure Drugs: Inotropic Agents